Related Experiment Videos
[Transgenic chickens]
1Centraal Diergeneeskundig Instituut, Afd. Virologie, Lelystad.
Tijdschrift Voor Diergeneeskunde
|May 15, 1990
Summary
Transgenic chickens offer disease resistance and biomedical protein production potential. Research is ongoing to overcome challenges in developing these genetically modified birds for practical applications.
Area of Science:
- * Molecular Biology and Genetics: Focuses on the creation and application of transgenic organisms.
- * Virology: Investigates viral mechanisms and disease resistance strategies.
- * Biotechnology: Explores the use of genetic engineering for practical benefits.
Context:
- * Transgenic mice are established using methods like retroviral insertion and micro-injection.
- * Transgenic chickens have primarily been created using avian leukemia virus (ALV) and reticuloendotheliosis (REV) retroviral vectors.
- * Replication-defective vectors are preferred to prevent infectious virus production, with REV vectors being particularly useful for chickens.
Purpose:
- * To explore methods for generating transgenic chickens.
- * To investigate strategies for conferring disease resistance in poultry, specifically against ALV infection.
- * To assess the potential for producing biomedical proteins in transgenic chickens.
Summary:
- * Transgenic chickens can be produced using replication-defective retroviral vectors, with REV vectors being highly applicable due to the absence of endogenous REV sequences in chickens.
- * Disease resistance, such as against ALV, can be achieved by blocking viral receptors in transgenic chickens.
- * Future applications may include inhibiting viral replication with antisense DNA and producing biomedical proteins, though significant research is still required.
Impact:
- * Development of disease-resistant poultry, reducing economic losses in the agricultural sector.
- * Potential for the large-scale production of valuable biomedical proteins in a cost-effective manner.
- * Advancement of vaccine technology, moving from live-virus vaccines to subunit and recombinant DNA vaccines.